rubella virus

GPTKB entity

Statements (58)
Predicate Object
gptkbp:instance_of gptkb:virus
gptkbp:bfsLayer 6
gptkbp:bfsParent gptkb:rubella
gptkbp:caused_by gptkb:rubella
gptkbp:clinical_trial mild illness in children
more severe in adults
gptkbp:collaborations elimination programs
gptkbp:complications gptkb:congenital_rubella_syndrome
gptkbp:data_usage higher in unvaccinated populations
gptkbp:discovered_by gptkb:1962
gptkbp:family gptkb:Togaviridae
gptkbp:genus gptkb:Rubivirus
gptkbp:healthcare promoting vaccination
reduction in congenital rubella syndrome
gptkbp:historical_significance linked to birth defects
https://www.w3.org/2000/01/rdf-schema#label rubella virus
gptkbp:incubation_period 2 to 3 weeks
gptkbp:is_affected_by pregnant women
gptkbp:is_compared_to varies by region
gptkbp:is_monitored_by mandatory reporting in many countries
gptkbp:is_protected_by vaccination
gptkbp:is_tested_for Ig M antibodies
Ig G seroconversion
gptkbp:is_vulnerable_to gptkb:MMR_vaccine
live attenuated
95% or higher
lifelong after infection
second dose at 4-6 years
first dose at 12-15 months
introduced in 1969
routine childhood vaccination
MR vaccine
post-vaccination
preconception vaccination
gptkbp:origin respiratory epithelium
fetal tissues
gptkbp:public_awareness importance of vaccination
gptkbp:research_focus genetic diversity
vaccine development
gptkbp:risk_factor travel to endemic areas
lack of vaccination
gptkbp:seed_dispersal single-stranded RNA
gptkbp:social_responsibility gptkb:measles
global distribution
serological testing
mumps
PCR testing
isolation during outbreaks
reported in unvaccinated populations
gptkbp:social_structure icosahedral symmetry
enveloped
gptkbp:status elimination in some regions
gptkbp:symptoms fever
rash
lymphadenopathy
gptkbp:transmission airborne droplets
gptkbp:treatment supportive care
no specific antiviral treatment